Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Clinical trial NCT06918912 · RECRUITING

Trial details

NCT number: NCT06918912
Sponsor: Istituto Clinico Humanitas
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma High-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma Treatment Relapsed or Refractory Lymphoma

Start date: 2023-06-16
Primary completion: 2025-03-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.